By David Bautz, PhD NASDAQ: ICU READ THE FULL ICU RESEARCH REPORT Business Update Presentations Highlight SAVE Registry Data ...

TRS is always an amazing highlight of the hard work and talent among our trainees in basic science and clinical research. For this year’s poster presentation, abstracts were submitted by undergraduate ...

BOSTON, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that clinical data from the ...

TOULOUSE, France & LAKELAND, Mich.--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma, (FR0012616852 - ABNX - eligible for PEA PME), a new generation biotech company dedicated to the discovery and ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of HIV research findings at the International Congress on Drug Therapy in HIV ...

At the 2024 Educational Research and Innovations in Clinical and Health Sciences (ENRICH) Week poster session, Hunter “Caroline” Davies secured first place in the innovation category for her poster, ...

Third-year Pathways MD student Emilie Baxter spent her first-year summer break at Mbarara Regional Referral Hospital in ...

CARLSBAD, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (QLGN) today announces that a poster featuring its early clinical experience with a novel first-in-class G-Quadruplex ...

The poster, titled “ TibuSURE: A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study with Open-Label Extension to Evaluate the Efficacy, Safety, and Tolerability of Tibulizumab ...

Labroots is excited to announce the 17th Annual Event in the Clinical Diagnostics & Research Virtual Event Series taking place on November 11th, 2026! This event will again bring together clinicians, ...